Evidence map›Paper›PMID 41590554›Full record

ReviewMembranes2025

From Environmental Threat to Control: A Review of Technologies for Removal of Quaternary Ammonium Compounds from Wastewater.

Aleksandra Klimonda, Izabela Kowalska

Abstract readReview
In one paragraph

Review in Membranes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Aleksandra KlimondaFaculty of Environmental Engineering, Wroclaw University of Science and Technology, Wybrzeże S. Wyspiańskiego 27, 50-370 Wrocław, Poland.
Izabela KowalskaFaculty of Environmental Engineering, Wroclaw University of Science and Technology, Wybrzeże S. Wyspiańskiego 27, 50-370 Wrocław, Poland.ORCID 0000-0003-0943-625X

Funding

Wrocław University of Science and Technology 825 305 0501
6 · The paper itself

Abstract

Cationic surfactants from the group of quaternary ammonium compounds (QACs) are widely used in disinfectants, cosmetics, and household and industrial products. Their strong antimicrobial activity and chemical stability make them valuable in applications but also highly persistent and toxic when released into aquatic environments. This problem has become increasingly relevant during and after the COVID-19 pandemic, when global use of QAC-based disinfectants increased drastically, resulting in their frequent detection in municipal, hospital, and industrial effluents. The concentrations of QACs reported in wastewater range from trace levels to several mg/L, often reaching inhibitory thresholds for biological treatment processes. Although surfactants are not listed in any current European directive, the revised Directive (EU) 2024/1440 classifies micropollutants as a priority group, imposing stricter environmental quality standards and mandatory monitoring requirements. Within this regulatory framework, QACs are recognized as compounds of emerging concern, and their effective removal from wastewater has become a critical challenge. This review summarizes the current knowledge on conventional treatment technologies (coagulation, adsorption, ion exchange, advanced oxidation, and biological processes) and membrane-based methods (ultrafiltration, nanofiltration, reverse osmosis, forward osmosis, and hybrid systems) for the removal of cationic surfactants from water and wastewater. Mechanisms of separation, performance, and operational limitations are discussed.

Indexed as

cationic surfactantsemerging contaminantsenvironmental pollution controlforward osmosismembrane separation technologymicropollutantsquaternary ammonium compounds

Identifiers

PMID41590554
PMCPMC12844268

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.